🔎 Trials Near Me

Home › Gliosarcoma

Gliosarcoma clinical trials recruiting in the U.S.

11 studies for Gliosarcoma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT03896568

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

RecruitingPhase 1
Ages 19 and older · All sexes · Updated Sep 14, 2026 · NCT05698524

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06934889

Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM

RecruitingPhase 1
Ages 12 and older · All sexes · Updated Sep 4, 2026 · NCT04991870

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT05756985

Study of Pembrolizumab and M032 (NSC 733972)

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jan 22, 2026 · NCT05084430

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 12, 2026 · NCT05465954

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT04541082

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.